Codexis Inc., 200 Penobscot Dr, Redwood City, CA, 94063, USA.
Codexis Inc., 200 Penobscot Dr, Redwood City, CA, 94063, USA.
Curr Opin Chem Biol. 2021 Oct;64:38-47. doi: 10.1016/j.cbpa.2021.03.005. Epub 2021 Apr 29.
Therapeutic proteins alleviate disease pathology by supplementing missing or defective native proteins, sequestering superfluous proteins, or by acting through designed non-natural mechanisms. Although therapeutic proteins often have the same amino acid sequence as their native counterpart, their maturation paths from expression to the site of physiological activity are inherently different, and optimizing protein sequences for properties that 100s of millions of years of evolution did not need to address presents an opportunity to develop better biological treatments. Because therapeutic proteins are inherently non-natural entities, optimization for their desired function should be considered analogous to that of small molecule drug candidates, which are optimized through expansive combinatorial variation by the medicinal chemist. Here, we review recent successes and challenges of protein engineering for optimized therapeutic efficacy.
治疗性蛋白通过补充缺失或有缺陷的天然蛋白、隔离多余的蛋白,或者通过设计的非天然机制来缓解疾病病理。虽然治疗性蛋白通常与天然蛋白具有相同的氨基酸序列,但它们从表达到生理活性部位的成熟途径在本质上是不同的,因此优化蛋白质序列以获得数百万年进化都不需要解决的特性为开发更好的生物治疗方法提供了机会。由于治疗性蛋白本质上是非天然的实体,因此对其预期功能的优化应该被认为类似于小分子药物候选物的优化,后者通过药物化学家的广泛组合变化进行优化。在这里,我们回顾了最近在优化治疗效果的蛋白质工程方面的成功和挑战。